These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 398193)

  • 21. [An automatic immunological method for the quantitative determination of tetanus antibodies (author's transl)].
    Ebeling H
    Z Klin Chem Klin Biochem; 1974 Feb; 12(2):54-8. PubMed ID: 4428828
    [No Abstract]   [Full Text] [Related]  

  • 22. Problems of persistance of Plectridium tetani in the portal of entry in patients with tetanus.
    Král L; Lonská V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(3):339-53. PubMed ID: 4890780
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the amino acids transformation of the liquid 10-days-old culture of Clostridium tetani. VI. Comparative quantitative determination of the free amino acid media and filtrates of the 10-day-old culture of Clostridium tetani].
    Klimek J
    Ann Univ Mariae Curie Sklodowska Med; 1965; 20():327-35. PubMed ID: 5334738
    [No Abstract]   [Full Text] [Related]  

  • 24. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-tetanus immunity and vaccination by the lingual route].
    Ruiz Merino J
    Rev Sanid Hig Publica (Madr); 1982; 56(5-6):469-77. PubMed ID: 6764298
    [No Abstract]   [Full Text] [Related]  

  • 27. [Physico-chemical studies of purified tetanus toxin and toxoid. I. Chromatographic, electrophoretic and oscillopolarographic studies].
    Klimek J
    Med Dosw Mikrobiol; 1969; 21(1):49-55. PubMed ID: 5789983
    [No Abstract]   [Full Text] [Related]  

  • 28. [A contribution on the active and passive vaccination against Clostridium novyi and Clostridium tetani].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):350-6. PubMed ID: 4233547
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control of tetanus from the immunobiological point of view].
    Zimmermann G
    Z Arztl Fortbild (Jena); 1975 Dec; 69(24):1284-6. PubMed ID: 766430
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isolation of Clostridium tetani from the upper molar milk teeth of a tetanus patient].
    TSUCHIYA T; OSHIMA H; GOTO J; DOI H; MORI T
    Iryo; 1962 Apr; 16():250-1. PubMed ID: 13922846
    [No Abstract]   [Full Text] [Related]  

  • 31. The sporulation of clostridium tetani.
    BISSET KA
    J Gen Microbiol; 1950 Jan; 4(1):1-3. PubMed ID: 15415550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Subtilin, VI: the structure of subtilin (author's transl)].
    Gross E; Kiltz HH; Nebelin E
    Hoppe Seylers Z Physiol Chem; 1973 Jul; 354(7):810-2. PubMed ID: 4154277
    [No Abstract]   [Full Text] [Related]  

  • 33. [A vaccine against tetanus with a higher level of tetanus toxoid].
    Kamenická L; Nováková I; Masár I; Tirco S; Magdová K
    Cesk Epidemiol Mikrobiol Imunol; 1989 Mar; 38(2):82-8. PubMed ID: 2653652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunity to tetanus in men 22-46 years of age as an index of efficacy of mass prophylactic vaccinations].
    Galazka A; Sporzyńska Z
    Przegl Epidemiol; 1973; 27(4):469-76. PubMed ID: 4591090
    [No Abstract]   [Full Text] [Related]  

  • 35. An unusual portal of entry for the Clostridium tetani; a draining ear.
    ROSA FEBLES C; RAMIREZ E; ARMAIZ G; TORREGROSA MV
    Bol Asoc Med P R; 1950 Apr; 42(4):243-4. PubMed ID: 15411436
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunity against tetanus 3 years after revaccination].
    Bozović M; Pavlović V
    Med Pregl; 1991; 44(1-2):77-8. PubMed ID: 1870472
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immune response to tetanus toxoid in bullous pemphigoid].
    Lohrisch I; Haustein UF; Baumert A; Szeskus H
    Dermatol Monatsschr; 1985; 171(3):153-7. PubMed ID: 3888705
    [No Abstract]   [Full Text] [Related]  

  • 38. Current concepts in the management of Clostridium tetani infection.
    Brook I
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):327-36. PubMed ID: 18588497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biology of the tetanus bacillus].
    FASQUELLE R; BERGOGNE E; POUTREL F
    Rev Prat; 1960 Feb; 10():467-75. PubMed ID: 13821667
    [No Abstract]   [Full Text] [Related]  

  • 40. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.